New federal agency partnership to focus on labor issues in merger investigations
By
Lois A. Bowers
Aug 29, 2024
The Department of Justice Antitrust Division, Department of Labor, Federal Trade Commission and National Labor Relations Board General Counsel will work together to “strengthen worker protections and...
Retirement is a time of reinvention, survey finds
By
Lois A. Bowers
Aug 29, 2024
In a new survey of people who recently have retired or will soon, 60% said that they view retirement as a time to reinvent themselves.
Business briefs, Aug, 29
By
Lois A. Bowers
Aug 29, 2024
Long-term care staffing agencies to pay $700,000 for overcharging providers … PruittHealth CEO named AHCA Quality Champion for 2024 … Massage therapy reduces burnout, improves well-being among RNs,...
Actions & Transaction, Aug. 29
By
Lois A. Bowers
Aug 29, 2024
JLL Capital Markets arranges $115 million bridge loan for four-state Town Village Portfolio … Experience Senior Living opens showroom in Denver for first senior living community under its new luxury...
Sensory disabilities tied to worse subsequent mental health in seniors
By
Haymarket Media
Aug 28, 2024
Increased risk for low self-rated mental health and loneliness symptoms were seen for older adults with more sensory disabilities.
Red flag laws prevent suicides
By
Haymarket Media
Aug 28, 2024
One life was saved for every 17 extreme risk protection orders to remove guns from people at risk for harming themselves or others.
Chronic diabetes complications bidirectionally linked to mental health disorders
By
Haymarket Media
Aug 28, 2024
The findings were seen across the life span and irrespective of diabetes type.
RSV infection with inflammatory bowel disease ups risk for hospitalization
By
Haymarket Media
Aug 28, 2024
“Adult patients with IBD and RSV infection … may benefit from the new RSV vaccine recommended for adults aged 60 years and older,” the authors write.
Mediterranean diet adherence may protect against COVID-19
By
Haymarket Media
Aug 28, 2024
The review shows unclear benefits against COVID-19 symptoms and severity.
Psilocybin has better response than placebo in antidepressant trials
By
Haymarket Media
Aug 28, 2024
Only high-dose psilocybin was better than placebo in antidepressant trials of escitalopram.